AP2607A - Piperidin-4-yl-pyridazin-3-ylamine derivatives as fast dissociating dopamine 2 receptor antagonists - Google Patents

Piperidin-4-yl-pyridazin-3-ylamine derivatives as fast dissociating dopamine 2 receptor antagonists

Info

Publication number: AP2607A
Authority: AP; ARIPO
Prior art keywords: pyridazin; piperidin; receptor antagonists; ylamine derivatives; fast dissociating
Prior art date: 2005-10-26

Application number

AP2008004441A

Other languages

English (en)

Other versions

AP2008004441A0 (en

Inventor

Marcel Frans Leopold De Bruyn

Gregory James Macdonald

Ludo Edmond Josephine Kennis

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-10-26

Filing date

2006-10-24

Publication date

2013-03-05

2006-10-24 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2008-04-30 Publication of AP2008004441A0 publication Critical patent/AP2008004441A0/xx

2013-03-05 Application granted granted Critical

2013-03-05 Publication of AP2607A publication Critical patent/AP2607A/xx

Links

VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 title 2
229960003638 dopamine Drugs 0.000 title 1
CKODDUILXBOSEM-UHFFFAOYSA-N n-piperidin-4-ylpyridazin-3-amine Chemical class C1CNCCC1NC1=CC=CN=N1 CKODDUILXBOSEM-UHFFFAOYSA-N 0.000 title 1
239000002464 receptor antagonist Substances 0.000 title 1
229940044551 receptor antagonist Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Epidemiology (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Pain & Pain Management (AREA)
Psychology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AP2008004441A 2005-10-26 2006-10-24 Piperidin-4-yl-pyridazin-3-ylamine derivatives as fast dissociating dopamine 2 receptor antagonists AP2607A (en)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
EP05110028		2005-10-26
EP06100209		2006-01-10
EP06101545		2006-02-10
PCT/EP2006/067696 WO2007048779A1 (en)	2005-10-26	2006-10-24	Piperidin-4-yl-pyridazin-3-ylamine derivatives as fast dissociating dopamine 2 receptor antagonists

Publications (2)

Publication Number	Publication Date
AP2008004441A0 AP2008004441A0 (en)	2008-04-30
AP2607A true AP2607A (en)	2013-03-05

Family

ID=35734993

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AP2008004441A AP2607A (en)	2005-10-26	2006-10-24	Piperidin-4-yl-pyridazin-3-ylamine derivatives as fast dissociating dopamine 2 receptor antagonists

Country Status (34)

Country	Link
US (3)	US8940743B2 (sr)
EP (1)	EP1943242B1 (sr)
JP (1)	JP5140598B2 (sr)
KR (1)	KR101351910B1 (sr)
CN (1)	CN101291925B (sr)
AP (1)	AP2607A (sr)
AR (1)	AR058151A1 (sr)
AT (1)	ATE495167T1 (sr)
AU (1)	AU2006307930B2 (sr)
BR (1)	BRPI0617787A2 (sr)
CA (1)	CA2623160C (sr)
CR (1)	CR10020A (sr)
CY (1)	CY1111977T1 (sr)
DE (1)	DE602006019624D1 (sr)
DK (1)	DK1943242T3 (sr)
EA (1)	EA015681B1 (sr)
EC (1)	ECSP088396A (sr)
ES (1)	ES2359020T3 (sr)
GT (1)	GT200800033A (sr)
HN (1)	HN2008000646A (sr)
HR (1)	HRP20110226T1 (sr)
IL (1)	IL191016A (sr)
JO (1)	JO2769B1 (sr)
MY (1)	MY145609A (sr)
NO (1)	NO20082350L (sr)
NZ (1)	NZ566785A (sr)
PL (1)	PL1943242T3 (sr)
PT (1)	PT1943242E (sr)
RS (1)	RS51674B (sr)
SI (1)	SI1943242T1 (sr)
TW (1)	TWI399373B (sr)
UA (1)	UA94058C2 (sr)
WO (1)	WO2007048779A1 (sr)
ZA (1)	ZA200803668B (sr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JO2769B1 (en)	2005-10-26	2014-03-15	جانسين فارماسوتيكا ان. في	Rapid decomposition of physiologically antagonistic agents of the 2-dopamine receptor
JO2642B1 (en) *	2006-12-08	2012-06-17	جانسين فارماسوتيكا ان. في	Dopamine 2 receptor antagonists are rapidly hydrolyzed
JO2849B1 (en)	2007-02-13	2015-03-15	جانسين فارماسوتيكا ان. في	Dopamine 2 receptor antagonists are rapidly hydrolyzed
RU2489431C2 (ru) *	2007-04-23	2013-08-10	Янссен Фармацевтика Н.В.	Тиа(диа)золы как быстро диссоциирующие антагонисты рецептора допамина 2
AU2008240727C1 (en) *	2007-04-23	2013-10-03	Janssen Pharmaceutica N.V.	Pyridine derivatives as fast dissociating dopamine 2 receptor antagonists
JP5431305B2 (ja)	2007-04-23	2014-03-05	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	高速解離性ドパミン２受容体アンタゴニストとしての４−アルコキシピリダジン誘導体
CA2687931C (en) *	2007-05-31	2016-05-24	Boehringer Ingelheim International Gmbh	Ccr2 receptor antagonists and uses thereof
JP5417439B2 (ja) *	2008-07-03	2014-02-12	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	５−ｈｔ６受容体アンタゴニストとしての置換された６−（１−ピペラジニル）−ピリダジン類
US20100041663A1 (en)	2008-07-18	2010-02-18	Novartis Ag	Organic Compounds as Smo Inhibitors
EA019048B1 (ru) *	2008-07-31	2013-12-30	Янссен Фармацевтика Нв	Пиперазин-1-илтрифторметилзамещенные пиридины в качестве быстро диссоциирующихся антагонистов d-рецепторов дофамина
ES2551557T3 (es)	2008-12-19	2015-11-19	Boehringer Ingelheim International Gmbh	Pirimidin-4-carboxamidas cíclicas como antagonistas del receptor CCR2 para el tratamiento de inflamaciones, asma y EPOC
PH12012500778A1 (en)	2009-10-30	2012-11-26	Janssen Pharmaceutica Nv	IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES AND THEIR USE AS PDE10 INHIBITORS
PL2513093T3 (pl)	2009-12-17	2015-03-31	Centrexion Therapeutics Corp	Nowi antagoniści receptora CCR2 i ich zastosowanie
AR080754A1 (es)	2010-03-09	2012-05-09	Janssen Pharmaceutica Nv	Derivados de imidazo (1,2-a) pirazina y su uso como inhibidores de pde10
JP5721242B2 (ja)	2010-06-01	2015-05-20	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	新規ｃｃｒ２アンタゴニスト
JP6115962B2 (ja)	2011-06-27	2017-04-19	ヤンセンファーマシューティカエヌ．ベー．	１−アリール−４−メチル−［１，２，４］トリアゾロ［４，３−ａ］キノキサリン誘導体
WO2014001314A1 (en)	2012-06-26	2014-01-03	Janssen Pharmaceutica Nv	Combinations comprising pde 2 inhibitors such as 1-aryl-4-methyl- [1,2,4] triazolo [4,3-a] quinoxaline compounds and pde 10 inhibitors for use in the treatment of neurological or metabolic disorders
AU2013289284B2 (en)	2012-07-09	2017-03-30	Janssen Pharmaceutica Nv	Inhibitors of phosphodiesterase 10 enzyme
MX383744B (es)	2015-07-02	2025-03-14	Centrexion Therapeutics Corp	Citrato de (4-((3r,4r)-3-metoxitetrahidro-piran-4-ilamino)piperidin-1-il) (5-metil-6-(((2r, 6s)-6-(p-tolil)tetrahidro-2h-piran-2-il) metilamino) pirimidin-4-il) metanona.
US20180350708A1 (en) *	2017-06-06	2018-12-06	Powertech Technology Inc.	Package structure and manufacturing method thereof
EP4574152A1 (en)	2023-12-22	2025-06-25	Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.	Potassium channel activators for use in the treatment of epileptic disorders

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1999009025A2 (en) *	1997-08-15	1999-02-25	Pfizer Products Inc.	2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1h-indole derivatives interacting with the dopamine d4 receptor

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3933823A (en)	1971-03-29	1976-01-20	E. R. Squibb & Sons, Inc.	Isoxazolopyridine ketone derivatives
DE2341965C3 (de)	1973-08-20	1979-01-25	C.H. Boehringer Sohn, 6507 Ingelheim	4- [N- (o-PyridyD- N-acyl] -aminolphenäthylpiperidine, Verfahren zu deren Herstellung sowie deren Verwendung bei der Bekämpfung von Schmerzzuständen
NO147672C (no)	1975-09-23	1983-05-25	Janssen Pharmaceutica Nv	Analogifremgangsmaate for fremstilling av n-aryl-n-(1-l1-4-piperidinyl)-arylacetamider
US4197304A (en)	1975-09-23	1980-04-08	Janssen Pharmaceutica N.V.	N-Aryl-N-(1-L-4-piperidinyl)-arylacetamides
EG12406A (en)	1976-08-12	1979-03-31	Janssen Pharmaceutica Nv	Process for preparing of novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
DE3218482A1 (de)	1982-05-15	1983-11-17	Bayer Ag, 5090 Leverkusen	Substituierte 5-trifluormethyl-1,3,4-thiadiazol-2-yloxyessigsaeureamide, verfahren zu ihrer herstellung und ihre verwendung als herbizide
ES8802151A1 (es)	1985-07-31	1988-04-01	Janssen Pharmaceutica Nv	Un procedimiento para la preparacion de nuevos piridazinaminas.
MX173362B (es)	1987-03-02	1994-02-23	Pfizer	Compuestos de piperazinil heterociclicos y procedimiento para su preparacion
PT93060B (pt)	1989-02-07	1995-12-29	Sanofi Sa	Processo para a obtencao de derivados de piridazina e de composicoes farmaceuticas que os contem
US5461053A (en)	1989-02-07	1995-10-24	Sanofi	Pyridazine derivatives
GB9008850D0 (en) *	1990-04-19	1990-06-13	Janssen Pharmaceutica Nv	Novel 2,9-disubstituted-4h-pyridol(1,2-a)pyrimidin-4-ones
GB9216298D0 (en)	1991-08-15	1992-09-16	Ici Plc	Piperidine derivatives
DE69419778T2 (de)	1993-12-28	1999-12-09	Pharmacia & Upjohn Co., Kalamazoo	Heterozyklische verbindungen für die behandlung von kardiovaskular- und zentralnervensystem störungen
DE4425145A1 (de)	1994-07-15	1996-01-18	Basf Ag	Verwendung von Thiazol- und Thiadiazolverbindungen
TW406075B (en)	1994-12-13	2000-09-21	Upjohn Co	Alkyl substituted piperidinyl and piperazinyl anti-AIDS compounds
US5560931A (en)	1995-02-14	1996-10-01	Nawosystems L.L.C.	Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids
US5753679A (en)	1995-05-10	1998-05-19	Hoffmann-La Roche Inc.	Benzyl-piperidine derivatives
MY116093A (en)	1996-02-26	2003-11-28	Upjohn Co	Azolyl piperazinyl phenyl oxazolidinone antimicrobials
TW504510B (en) *	1996-05-10	2002-10-01	Janssen Pharmaceutica Nv	2,4-diaminopyrimidine derivatives
KR100261139B1 (ko)	1998-01-16	2000-08-01	황준수	신규한 알릴티오피리다진 유도체 및 그의 제조방법
AR028948A1 (es)	2000-06-20	2003-05-28	Astrazeneca Ab	Compuestos novedosos
MXPA03007621A (es)	2001-02-23	2003-12-04	Merck & Co Inc	Antagonistas nr2b de n-metil-d-aspartato no arilheterociclicos n-sustituidos.
US7375115B2 (en)	2001-10-09	2008-05-20	Kyorin Pharmaceutical Co., Ltd.	4-(2-furoyl) aminopiperidines, intermediates in synthesizing the same, process for producing the same and medicinal use of the same
GB0127832D0 (en)	2001-11-20	2002-01-09	Jagotec Ag	Method for the preparation of pharmaceutical nanosuspensions
US7812035B2 (en)	2001-12-11	2010-10-12	Sepracor Inc.	4-substituted piperidines, and methods of use thereof
EP1467981A1 (en)	2002-01-25	2004-10-20	Kylix Pharmaceuticals B.V.	4(hetero-) aryl substituted (thia-/oxa-/pyra) zoles for inhibition of tie-2
US20030236259A1 (en)	2002-02-05	2003-12-25	Rolf Hohlweg	Novel aryl- and heteroarylpiperazines
PL372390A1 (en)	2002-02-05	2005-07-25	Novo Nordisk A/S	Novel aryl- and heteroarylpiperazines
EP1476428B1 (en)	2002-02-22	2010-11-17	Pharmacia & Upjohn Company LLC	Pyridyl sulfone derivatives as 5-ht6 receptor ligands
SE0201544D0 (sv)	2002-05-17	2002-05-17	Biovitrum Ab	Novel compounds and thier use
AU2003272892A1 (en)	2002-09-26	2004-04-19	Mandom Corporation	Antiseptic bactericides and cosmetics, drugs and foods containing the antiseptic bactericides
ES2211344B1 (es)	2002-12-26	2005-10-01	Almirall Prodesfarma, S.A.	Nuevos derivados de piridazin-3(2h)-ona.
WO2004085406A1 (en)	2003-03-24	2004-10-07	F. Hoffmann-La Roche Ag	Benzyl-pyridazinons as reverse transcriptase inhibitors
EP1628626B2 (de)	2003-05-07	2013-12-04	OTC GmbH	Zusammensetzungen zur gezielten freisetzung von duftstoffen und aromen
CN100582103C (zh)	2003-05-08	2010-01-20	杏林制药株式会社	作为搔痒治疗药有效的4-(2-呋喃甲酰基)氨基哌啶类化合物
WO2005005779A2 (en)	2003-07-14	2005-01-20	Genesis Mining Technologies (Pty) Ltd	Dual retention cutting arrangement
MXPA06001053A (es)	2003-07-29	2006-04-11	Novo Nordisk As	Piridazinil-piperazinas y su uso como ligandos del receptor de histamina h3.
EP2316827B1 (en)	2003-07-30	2016-01-27	Xenon Pharmaceuticals Inc.	Piperazine derivatives and their use as therapeutic agents
WO2005013907A2 (en)	2003-08-07	2005-02-17	Japan Tobacco Inc.	Pyrrolo[1,2-b]pyridazine derivatives
CN1871342B (zh)	2003-10-24	2010-12-15	程涛	p18对干细胞的调控
CA2555227A1 (en)	2004-02-10	2005-08-25	Janssen Pharmaceutica, N.V.	Pyridazinone ureas as antagonists of .alpha.4 integrins
EP1730120A1 (en)	2004-03-23	2006-12-13	F.Hoffmann-La Roche Ag	Non-nucleoside reverse transcriptase inhibitors
US20070225333A1 (en)	2004-04-28	2007-09-27	Bryans Justin S	3-Heterocyclyl-4-Phenyl-Triazole Derivatives as Inhibitors of the Vasopressin Via Receptor
AU2005249494A1 (en)	2004-05-28	2005-12-15	Vertex Pharmaceuticals Incorporated	Modulators of muscarinic receptors
ES2251866B1 (es)	2004-06-18	2007-06-16	Laboratorios Almirall S.A.	Nuevos derivados de piridazin-3(2h)-ona.
ES2251867B1 (es)	2004-06-21	2007-06-16	Laboratorios Almirall S.A.	Nuevos derivados de piridazin-3(2h)-ona.
US7767677B2 (en)	2004-09-20	2010-08-03	Xenon Pharmaceuticals Inc.	Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
RU2384576C2 (ru)	2004-10-29	2010-03-20	Калипсис, Инк	Сульфонил-замещенные бициклические соединения в качестве модуляторов ppar
EP1868652A2 (en)	2005-04-05	2007-12-26	Istituto di Richerche di Biologia Molecolare P. Angeletti S.p.A.	Method for shielding functional sites or epitopes on proteins
DE602006010870D1 (de)	2005-06-20	2010-01-14	Schering Corp	Als antagonisten von histamin h3 geeignete piperidinderivate
JO2769B1 (en) *	2005-10-26	2014-03-15	جانسين فارماسوتيكا ان. في	Rapid decomposition of physiologically antagonistic agents of the 2-dopamine receptor
WO2007130383A2 (en)	2006-04-28	2007-11-15	Northwestern University	Compositions and treatments using pyridazine compounds and secretases
KR101117931B1 (ko)	2006-08-15	2012-04-12	에프. 호프만-라 로슈 아게	페닐, 피리딘 및 퀴놀린 유도체
CA2606658A1 (en)	2006-10-13	2008-04-13	Mike Tyers	Compositions and methods for treating neurological disorders or damage
TW200829566A (en)	2006-12-08	2008-07-16	Astrazeneca Ab	Chemical compounds
JO2642B1 (en)	2006-12-08	2012-06-17	جانسين فارماسوتيكا ان. في	Dopamine 2 receptor antagonists are rapidly hydrolyzed
JO2849B1 (en)	2007-02-13	2015-03-15	جانسين فارماسوتيكا ان. في	Dopamine 2 receptor antagonists are rapidly hydrolyzed
JP5431305B2 (ja)	2007-04-23	2014-03-05	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	高速解離性ドパミン２受容体アンタゴニストとしての４−アルコキシピリダジン誘導体
AU2008240727C1 (en)	2007-04-23	2013-10-03	Janssen Pharmaceutica N.V.	Pyridine derivatives as fast dissociating dopamine 2 receptor antagonists
RU2489431C2 (ru)	2007-04-23	2013-08-10	Янссен Фармацевтика Н.В.	Тиа(диа)золы как быстро диссоциирующие антагонисты рецептора допамина 2
JP2010539218A (ja)	2007-09-20	2010-12-16	グラクソグループリミテッド	Ｍ１受容体にて活性を有する化合物および医薬としてのそれらの使用
JP5417439B2 (ja)	2008-07-03	2014-02-12	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	５−ｈｔ６受容体アンタゴニストとしての置換された６−（１−ピペラジニル）−ピリダジン類
EA019048B1 (ru)	2008-07-31	2013-12-30	Янссен Фармацевтика Нв	Пиперазин-1-илтрифторметилзамещенные пиридины в качестве быстро диссоциирующихся антагонистов d-рецепторов дофамина

2006
- 2006-10-12 JO JO2006368A patent/JO2769B1/en active
- 2006-10-24 DK DK06807495.4T patent/DK1943242T3/da active
- 2006-10-24 SI SI200630966T patent/SI1943242T1/sl unknown
- 2006-10-24 MY MYPI20081298A patent/MY145609A/en unknown
- 2006-10-24 EA EA200801184A patent/EA015681B1/ru unknown
- 2006-10-24 RS RS20110153A patent/RS51674B/sr unknown
- 2006-10-24 NZ NZ566785A patent/NZ566785A/en not_active IP Right Cessation
- 2006-10-24 DE DE602006019624T patent/DE602006019624D1/de active Active
- 2006-10-24 HR HR20110226T patent/HRP20110226T1/hr unknown
- 2006-10-24 PL PL06807495T patent/PL1943242T3/pl unknown
- 2006-10-24 AT AT06807495T patent/ATE495167T1/de active
- 2006-10-24 PT PT06807495T patent/PT1943242E/pt unknown
- 2006-10-24 BR BRPI0617787-5A patent/BRPI0617787A2/pt not_active IP Right Cessation
- 2006-10-24 AU AU2006307930A patent/AU2006307930B2/en not_active Ceased
- 2006-10-24 AP AP2008004441A patent/AP2607A/xx active
- 2006-10-24 ES ES06807495T patent/ES2359020T3/es active Active
- 2006-10-24 KR KR1020087011462A patent/KR101351910B1/ko not_active Expired - Fee Related
- 2006-10-24 EP EP06807495A patent/EP1943242B1/en active Active
- 2006-10-24 JP JP2008537078A patent/JP5140598B2/ja not_active Expired - Fee Related
- 2006-10-24 UA UAA200803291A patent/UA94058C2/ru unknown
- 2006-10-24 US US12/091,219 patent/US8940743B2/en active Active
- 2006-10-24 CA CA2623160A patent/CA2623160C/en not_active Expired - Fee Related
- 2006-10-24 WO PCT/EP2006/067696 patent/WO2007048779A1/en not_active Ceased
- 2006-10-24 CN CN2006800389935A patent/CN101291925B/zh active Active
- 2006-10-25 TW TW095139268A patent/TWI399373B/zh not_active IP Right Cessation
- 2006-10-25 AR ARP060104659A patent/AR058151A1/es unknown
2008
- 2008-03-31 GT GT200800033A patent/GT200800033A/es unknown
- 2008-04-23 HN HN2008000646A patent/HN2008000646A/es unknown
- 2008-04-23 EC EC2008008396A patent/ECSP088396A/es unknown
- 2008-04-25 ZA ZA200803668A patent/ZA200803668B/xx unknown
- 2008-04-27 IL IL191016A patent/IL191016A/en active IP Right Grant
- 2008-05-26 NO NO20082350A patent/NO20082350L/no not_active Application Discontinuation
- 2008-05-26 CR CR10020A patent/CR10020A/es unknown
2011
- 2011-04-12 CY CY20111100375T patent/CY1111977T1/el unknown
2015
- 2015-01-26 US US14/605,873 patent/US9468640B2/en active Active
2016
- 2016-09-13 US US15/264,185 patent/US9751860B2/en active Active

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1999009025A2 (en) *	1997-08-15	1999-02-25	Pfizer Products Inc.	2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1h-indole derivatives interacting with the dopamine d4 receptor

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MORAGUES J ET AL.: "DOPAMINERGIC ACTIVITY IN A SERIES OF N-SUBSTITUTED 2-AMINOPYRIMIDINES" FARMACO, EDIZIONE SCIENTIFICA, SOCIETA CHIMICA ITALIANA, PAVIA, IT, vol. 35, no. 11, 1980, pages 951-964, XP009032424 ISSN: 0430-0920 cited in the application page 959 - page 960; table II; compounds IA-IS *

Also Published As

Publication number	Publication date
HK1124317A1 (en)	2009-07-10
RS51674B (sr)	2011-10-31
CY1111977T1 (el)	2015-11-04
PT1943242E (pt)	2011-04-06
JO2769B1 (en)	2014-03-15
US9468640B2 (en)	2016-10-18
EA015681B1 (ru)	2011-10-31
AU2006307930A1 (en)	2007-05-03
US20150141432A1 (en)	2015-05-21
NZ566785A (en)	2010-03-26
UA94058C2 (ru)	2011-04-11
US8940743B2 (en)	2015-01-27
MY145609A (en)	2012-03-15
HRP20110226T1 (hr)	2011-05-31
HN2008000646A (es)	2011-02-16
CN101291925A (zh)	2008-10-22
KR101351910B1 (ko)	2014-01-16
TW200732321A (en)	2007-09-01
ZA200803668B (en)	2009-09-30
AP2008004441A0 (en)	2008-04-30
KR20080067658A (ko)	2008-07-21
EP1943242B1 (en)	2011-01-12
PL1943242T3 (pl)	2011-06-30
AU2006307930B2 (en)	2011-10-06
US20080227791A1 (en)	2008-09-18
TWI399373B (zh)	2013-06-21
JP2009514815A (ja)	2009-04-09
WO2007048779A1 (en)	2007-05-03
US9751860B2 (en)	2017-09-05
DK1943242T3 (da)	2011-04-26
IL191016A (en)	2013-10-31
CA2623160C (en)	2013-10-15
CA2623160A1 (en)	2007-05-03
ATE495167T1 (de)	2011-01-15
ES2359020T3 (es)	2011-05-17
BRPI0617787A2 (pt)	2009-12-01
DE602006019624D1 (de)	2011-02-24
EA200801184A1 (ru)	2008-08-29
AR058151A1 (es)	2008-01-23
JP5140598B2 (ja)	2013-02-06
ECSP088396A (es)	2008-05-30
US20170022181A1 (en)	2017-01-26
SI1943242T1 (sl)	2011-05-31
CR10020A (es)	2009-01-16
EP1943242A1 (en)	2008-07-16
NO20082350L (no)	2008-07-01
GT200800033A (es)	2009-08-20
CN101291925B (zh)	2013-04-10

Publication	Publication Date	Title
ZA200803668B (en)	2009-09-30	Piperidin-4-yl-pyridazin-3-ylamine derivatives as fast dissociating dopamine 2 receptor antagonists
ZA200800320B (en)	2009-02-25	Indol-3-carbonyl-spiro-piperidine derivatives as Via receptor antagonists
ZA200709147B (en)	2009-08-26	Pyrimidindione derivatives as prokineticin 2 receptor antagonists
IL200310A (en)	2013-07-31	4-aryl-6-piperazine-1-yl-pyridines as fast-breaking dopamine 2 antagonists
IL201663A0 (en)	2010-05-31	4-alkoxypyridazine derivatives as fast dissociating dopamine 2 receptor antagonists
ZA200710169B (en)	2008-12-31	Piperidin-4-yl-amide derivatives and their use as SST receptor subtype 5 antagonists
IL184233A0 (en)	2007-10-31	2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists
ZA200801432B (en)	2009-07-29	Carboxamide derivatives as muscarinic receptor antagonists
IL188806A0 (en)	2008-08-07	Substituted piperazines as metabotropic glutamate receptor antagonists
IL192308A0 (en)	2009-02-11	Oxazoloisoquinoline derivatives as thrombin receptor antagonists
LT2307374T (lt)	2017-04-25	Piperazin-1-il-trifluormetil-pakeistieji piridinai kaip greitai disocijuojantys dopamino 2 receptoriaus antagonistai
AP2006003840A0 (en)	2006-12-31	Indole-2-carboxamidine derivatives as NMDA receptor antagonists
PL2091938T3 (pl)	2011-04-29	Piperydynyloaminipirazyny i ich zastosowanie jako szybko dysocjujących antagonistów receptora dopaminy 2
IL201661A0 (en)	2010-05-31	Thia(dia) zoles as fast dissociating dopamine 2 receptor antagonists
IL201662A0 (en)	2010-05-31	Pyridine derivatives as fast dissociating dopamine 2 receptor antagonists
ZA200802339B (en)	2009-10-28	Indol-3-yl-carbonyl-azaspiro derivatives as vasopressin receptor antagonists
PT1912976E (pt)	2009-01-07	Derivados de indol-3-il-carboni-piperidin-benzimidazole como antagonistas dos receptores v1a
ZA200800516B (en)	2008-12-31	Indol-3-yl-carbonyl-piperidin-benzoimidazol derivatives as V1a receptor antagonists